Likes Subject
https://finance.yahoo.com/news/obseva-announces-sale-ebopiprant-license-12000080 Anite 11/22/22 12:57 PM
Why is this moving INFINITI 11/22/22 9:53 AM
OBSV...............................https://stockcharts.com/h-sc/ui?s=OBSV&p=W&b= glenn1919 08/07/22 12:36 PM
https://youtu.be/upInjNbeXAQ Here is the video why women are around FLY HIGH NOW 07/30/22 11:39 PM
Might buy some mid 20s willlbone 07/28/22 10:18 AM
Cheapies INFINITI 07/27/22 3:48 PM
Little reversal here INFINITI 07/27/22 1:21 PM
Maybe a buyout candidate now with such weakness? TCaine 07/27/22 12:01 PM
Any thoughts on how low this will go? TCaine 07/27/22 11:54 AM
the use of the procedure seems aimed at Frankestin 07/27/22 7:48 AM
the use of the procedure seems aimed at Frankestin 07/27/22 7:48 AM
it is not a failure but it looks Frankestin 07/27/22 6:42 AM
well but here with news like this we Frankestin 07/27/22 3:59 AM
the temptation is great but I'm not selling! Frankestin 06/28/22 4:12 PM
ObsEva Announces UK MHRA Marketing Authorization for Yselty® (linzagolix) Frankestin 06/28/22 4:03 PM
$ 1,77 Frankestin 06/27/22 11:51 AM
how much patience here! Frankestin 06/24/22 3:28 PM
https://www.healio.com/news/womens-health-ob-gyn/20220509/video-linzagolix-is-a- Frankestin 06/23/22 4:11 AM
after all it is a positive day, with Frankestin 06/17/22 10:45 AM
Uterine fibroids are the most common benign pelvic Frankestin 06/17/22 8:26 AM
let's scratch a little Frankestin 06/17/22 7:53 AM
https://investorshub.advfn.com/uimage/uploads/2022/6/17/rhyxvnumber.png[/im Frankestin 06/17/22 4:15 AM
The approval is based on positive data from Frankestin 06/17/22 4:06 AM
The NDA for linzagolix in the U.S. is Frankestin 06/17/22 4:03 AM
ObsEva today announced that the European Commission (EC) Frankestin 06/17/22 4:03 AM
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:2 Frankestin 05/25/22 2:30 AM
Ms. Clancy commented, “I’m honored to be reprising Frankestin 05/23/22 2:02 AM
Geneva, Switzerland and Boston, MA – April 7, Frankestin 05/18/22 2:29 AM
ObsEva Announces First Quarter 2022 Financial Results and Pan_O_War 05/17/22 6:30 AM
ObsEva Presents Clinical Data on Oral GnRH Antagonist Pan_O_War 05/09/22 6:20 AM
https://www.globenewswire.com/news-release/2022/05/09/2438181/0/en/ObsEva-Presen Frankestin 05/09/22 3:31 AM
i hope no good news comes out!https://investorshub.advfn.com/uimage/uploads Frankestin 05/05/22 1:57 PM
According to the U.S. National Institutes of Health Frankestin 04/22/22 3:40 PM
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/yselty Frankestin 04/22/22 3:21 PM
https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-opinion-yselty_ Frankestin 04/22/22 3:20 PM
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-product Frankestin 04/22/22 3:16 PM
3.6. Initial applications in the decision-making phase Frankestin 04/21/22 4:09 PM
$OBSV ObsEva CEO: «We are planning ObsEva 2.0» Pan_O_War 04/13/22 7:13 AM
https://www.obseva.com/wp-content/uploads/2022/03/ObsEva-Annual-Report-2021.pdf Frankestin 04/01/22 2:35 AM
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/yselty Frankestin 03/25/22 6:30 AM
Elizabeth Garner, MD, MPH, Chief Medical Officer of Frankestin 03/22/22 9:00 AM
ObsEva Announces Additional Efficacy Results for Linzagolix 200 Pan_O_War 03/22/22 8:22 AM
ObsEva Announces Year End 2021 Financial Results and Pan_O_War 03/10/22 6:03 AM
Additional data from the 6-month analysis are expected Frankestin 03/10/22 4:15 AM
ObsEva is working with the EMA toward approval, Frankestin 03/10/22 4:13 AM
Article 8 is specific or just general. Pan_O_War 02/23/22 6:26 AM
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-product Frankestin 02/22/22 12:55 PM
They are small but They are the right one! Frankestin 02/11/22 4:17 AM
ObsEva Enters into Licensing Agreement with Theramex for Pan_O_War 02/10/22 4:21 PM
+50,000 Shares Insider buying Pan_O_War 02/10/22 5:53 AM
Likes Subject

INFINITI
11/22/22 9:53 AM
willlbone
07/28/22 10:18 AM
INFINITI
07/27/22 3:48 PM
INFINITI
07/27/22 1:21 PM
TCaine
07/27/22 11:54 AM
Frankestin
07/27/22 7:48 AM
Frankestin
07/27/22 7:48 AM
Frankestin
07/27/22 6:42 AM
Frankestin
07/27/22 3:59 AM
Frankestin
06/28/22 4:12 PM
Frankestin
06/27/22 11:51 AM
Frankestin
06/24/22 3:28 PM
Frankestin
06/17/22 10:45 AM
Frankestin
06/17/22 7:53 AM
Frankestin
06/17/22 4:06 AM
Frankestin
06/17/22 4:03 AM
Pan_O_War
02/23/22 6:26 AM
Frankestin
02/11/22 4:17 AM
Pan_O_War
02/10/22 5:53 AM

ObsEva SA (OBSV)

Followers
20
Posters
31
Posts (Today)
0
Posts (Total)
258
Created
11/26/19
Type
Free
Moderators
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Most Liked Posts
(Last 30 Days)
New Post